Inotuzumab Ozogamicin Market Size, Competitive Landscape, Revenue...

σε πρόσθεσε στο Health

2023-07-11 09:01:29 - Μετάφραση -

Inotuzumab Ozogamicin Market Size, Competitive Landscape, Revenue Analysis, 2022–2027

Inotuzumab Ozogamicin Market is a combination of a monoclonal antibody and a chemotherapy drug used to treat B-cell acute lymphoblastic leukemia (ALL) that has relapsed or is unresponsive to treatment. The FDA has approved inotuzumab ozogamicin for treating adults with relapsed or refractory B-cell precursor ALL. The antibody component of inotuzumab ozogamicin binds to CD22 receptors, which...

0 Σχόλια 0 Μοιράστηκε 6χλμ. Views 0 Προεπισκόπηση